...
首页> 外文期刊>Thyroid: official journal of the American Thyroid Association >Combining the American Thyroid Association's Ultrasound Classification with Cytological Subcategorization Improves the Assessment of Malignancy Risk in Indeterminate Thyroid Nodules
【24h】

Combining the American Thyroid Association's Ultrasound Classification with Cytological Subcategorization Improves the Assessment of Malignancy Risk in Indeterminate Thyroid Nodules

机译:将美国甲状腺协会的超声分类与细胞学子类别相结合,提高了对不确定甲状腺结节中恶性风险的评估

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Background: The risk of malignancy (RoM) of indeterminate thyroid nodules (ITNs) shows a high variability in interinstitutional cohorts. The RoM is partially associated with the cytological degree of atypia and the ultrasound (US) pattern. This study evaluated the cancer risk of ITNs by jointly considering the cytological subcategory and the American Thyroid Association (ATA)-based US risk classification.Methods: This study features a retrospective cohort from two Brazilian centers comprising 238 ITNs with confirmed outcomes. US classification, according to ATA-based guidelines, and cytological subcategorization were determined. The cytological subgroups were as follows: (1) nuclear atypia (NA) related to papillary thyroid carcinoma (PTC) but insufficient to categorize the cytology as suspicious for malignancy; (2) architectural atypia without NA (AA); (3) both architectural and nuclear atypia (ANA); (4) oncocytic pattern (OP) without NA; and (5) NA not related to PTC (NANP). NA was divided into three subgroups: nuclear size and shape, nuclear membrane appearance, and/or chromatin aspects.Results: The overall frequency of malignancy was 39.5%. Among the cytological subcategories, the highest RoM was related to the NA (43.9%) and to the ANA (43.5%), followed by AA (29.4%), and OP (9.4%). NA was positively and independently associated with cancer (odds ratio [OR]: 4.5; confidence interval [CI: 1.2–16.6]) as was the occurrence of ANA (OR 6.6 [CI 1.5–29.5]). AA and OP were not independently associated with cancer. Both ATA-based high- and intermediate-risk categories showed an independent association with cancer (OR 6.8 [CI 2.9–15.5] and OR: 2.6 [CI 1.1–5.8], respectively). ITNs with cytological findings of NA or ANA when combined with intermediate US patterns had RoM values of 47.5% and 56.7%, respectively. Both cytological subcategories, when combined with the ATA high-suspicion class reached an RoM >70%. The type of NA with the highest odds for cancer was related to the nuclear membrane (OR 11.5).Conclusions: The RoM of ITNs can reach almost 80% when both NA and ATA-based high-risk US features are present. The presence of such cytological features also increased the RoM in the ATA-based intermediate-risk US category. In addition, AA and OP were not independently related to higher cancer risk. These results strengthen the recommendations for combing cytological subcategorization and US risk classification in the workup for ITNs before the decision of a molecular testing, clinical observation, or diagnostic surgery.
机译:背景:不确定甲状腺结节(ITN)的恶性风险(RoM)在机构间队列中表现出高度的可变性。RoM部分与异型性的细胞学程度和超声(US)模式有关。本研究通过联合考虑细胞学亚类和基于美国甲状腺协会(ATA)的美国风险分类来评估ITN的癌症风险。方法:本研究采用了来自两个巴西中心的回顾性队列研究,包括238个ITN,结果证实。根据基于ATA的指南进行美国分类,并确定细胞学亚分类。细胞学亚组如下:(1)与甲状腺乳头状癌(PTC)相关的细胞核异型性(NA),但不足以将细胞学分类为可疑的恶性肿瘤;(2) 无NA(AA)的建筑异型性;(3) 建筑和核异型性(ANA);(4) 无NA的嗜酸细胞型(OP);NA与PTC(NANP)无关。NA分为三个亚组:核大小和形状、核膜外观和/或染色质方面。结果:恶性肿瘤总发生率为39.5%。在细胞学亚类中,最高的RoM与NA(43.9%)和ANA(43.5%)有关,其次是AA(29.4%)和OP(9.4%)。NA与癌症呈正相关且独立(优势比[OR]:4.5;置信区间[CI:1.2-16.6]),与ANA的发生(OR 6.6[CI 1.5-29.5])。AA和OP与癌症无关。基于ATA的高风险和中等风险类别均显示出与癌症的独立关联(分别为OR 6.8[CI 2.9-15.5]和OR:2.6[CI 1.1-5.8])。细胞学结果为NA或ANA的ITN与中间US模式结合时,RoM值分别为47.5%和56.7%。这两个细胞学亚类与ATA高度怀疑分类相结合时,RoM>70%。癌症几率最高的NA类型与核膜有关(OR 11.5)。结论:当以NA和ATA为基础的高危超声特征同时存在时,ITN的RoM可以达到近80%。这些细胞学特征的存在也增加了以ATA为基础的中度风险美国分类的RoM。此外,AA和OP与更高的癌症风险无关。这些结果加强了在决定进行分子检测、临床观察或诊断性手术之前,在ITN检查中结合细胞学亚分类和US风险分类的建议。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号